NTRK1 and neoplasm: Amongst others, YB-1 activates gene expression of the epidermal growth factor receptor (EGFR), matrix metalloproteinase 2 (MMP-2) and of the receptor tyrosine kinase c-MET, all this associated with tumor cell adhesion, invasion and metastasis.